These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4320760)

  • 21. Homology between enterotoxin protein and spore structural protein in Clostridium perfringens type A.
    Frieben WR; Duncan CL
    Eur J Biochem; 1973 Nov; 39(2):393-401. PubMed ID: 4359628
    [No Abstract]   [Full Text] [Related]  

  • 22. Enterotoxemi of sheep. I. Effects of Clostridium perfringens type D toxin on the brains of sheep and mice.
    GRINER LA
    Am J Vet Res; 1961 May; 22():429-42. PubMed ID: 13708762
    [No Abstract]   [Full Text] [Related]  

  • 23. Heat resistance and alpha-toxigenicity of Clostridium perfringens strains in normal intestines of Japanese.
    Nakagawa M; Nishida S
    Jpn J Microbiol; 1969 Jun; 13(2):133-7. PubMed ID: 4309395
    [No Abstract]   [Full Text] [Related]  

  • 24. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristics of gel precipitating antigens of rubella virus.
    Salmi AA
    Arch Gesamte Virusforsch; 1970; 32(2):91-8. PubMed ID: 4993576
    [No Abstract]   [Full Text] [Related]  

  • 26. Titration of kappa toxin of Clostridium perfringens and kappa antitoxin by a modified azocoll method.
    Kameyama S; Akama K
    Jpn J Med Sci Biol; 1970 Feb; 23(1):31-46. PubMed ID: 4317539
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation of enterotoxigenic Clostridium perfringens type A to food poisoning. I. Effect of heat activation on the germination, sporulation and enterotoxigenesis of c. perfringens.
    Tsai CC; Riemann HP
    Taiwan Yi Xue Hui Za Zhi; 1974 Nov; 73(11):653-9. PubMed ID: 4375169
    [No Abstract]   [Full Text] [Related]  

  • 28. Purification and some properties of kappa toxin of Clostridium perfringens.
    Kameyama S; Akama K
    Jpn J Med Sci Biol; 1971 Feb; 24(1):9-23. PubMed ID: 4325624
    [No Abstract]   [Full Text] [Related]  

  • 29. The antigenic heterogenity of M protein of Streptococcus pyogenes (type 24).
    Havlícek J; Alouf JE; Raynaud M
    Zentralbl Bakteriol Orig; 1970; 214(3):390-2. PubMed ID: 4994145
    [No Abstract]   [Full Text] [Related]  

  • 30. Production and standardization of polyvalent Clostridium perfringens vaccine in Iran.
    Ardehali M; Darakhshan H
    Dev Biol Stand; 1976; 32():31-4. PubMed ID: 187509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of the antigenic composition of Cl. perfringens toxin and anatoxins].
    ISPOLATOVSKAIA MV; MARMALEVSKAIA LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():87-93. PubMed ID: 13718052
    [No Abstract]   [Full Text] [Related]  

  • 32. ISOLATION OF TOXIGENIC STRAINS OF CLOSTRIDIUM PERFRINGENS FROM SOIL.
    YAMAGISHI T; ISHIDA S; NISHIDA S
    J Bacteriol; 1964 Sep; 88(3):646-52. PubMed ID: 14208502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on allergy to intestinal flora. 1. Toxin activity of anticlostolysin theta in various diseases].
    Satomi T
    Arerugi; 1966 Jan; 15(1):48-54. PubMed ID: 4289610
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitation of Clostridium perfringens type A enterotoxin by electroimmunodiffusion.
    Duncan CL; Somers EB
    Appl Microbiol; 1972 Nov; 24(5):801-4. PubMed ID: 4344960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ISOLATION AND CHARACTERIZATION OF A TOXIC MOIETY OF LOW MOLECULAR WEIGHT FROM CLOSTRIDIUM BOTULINUM TYPE A.
    GERWING J; DOLMAN CE; BAINS HS
    J Bacteriol; 1965 May; 89(5):1383-6. PubMed ID: 14293025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Structure and function of Cl. perfringens toxin].
    Ispolatovskaia MV
    Vestn Akad Med Nauk SSSR; 1973; 28(11):83-9. PubMed ID: 4132138
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium perfringens exotoxins. I. Purification and properties of -toxin.
    Mitsu K; Mitsui N; Hase J
    Jpn J Exp Med; 1973 Apr; 43(2):65-80. PubMed ID: 4352113
    [No Abstract]   [Full Text] [Related]  

  • 39. A STUDY OF THE SOLUBLE ANTIGENS OF CLOSTRIDIUM PERFRINGENS TYPE D.
    HABEEB AF
    Can J Microbiol; 1964 Apr; 10():287-98. PubMed ID: 14171648
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of soluble antigens in guinea-pig epidermis. II. Physico-chemical characterizations of tissue-specific antigens.
    Aoki T; Parker D; Turk JL
    Immunology; 1969 Apr; 16(4):499-512. PubMed ID: 4181541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.